Progress in clinical development is measured through milestones. @​OragenicsNews recently achieved full activation of its Australian Phase IIa trial network an

Progress in clinical development is measured through milestones. @​OragenicsNews recently achieved full activation of its Australian Phase IIa trial network and submitted a Type B meeting request to the FDA as development of ONP-002 continues.